These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33486034)

  • 1. Simultaneous assessment of in vitro lipolysis and permeation in the mucus-PVPA model to predict oral absorption of a poorly water soluble drug in SNEDDSs.
    Falavigna M; Brurok S; Klitgaard M; Flaten GE
    Int J Pharm; 2021 Mar; 596():120258. PubMed ID: 33486034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Oral Absorption of fenofibrate in Lipid-Based Drug Delivery Systems by Combining In Vitro Lipolysis with the Mucus-PVPA Permeability Model.
    Falavigna M; Klitgaard M; Berthelsen R; Müllertz A; Flaten GE
    J Pharm Sci; 2021 Jan; 110(1):208-216. PubMed ID: 32916137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method.
    Klitgaard M; Müllertz A; Berthelsen R
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
    Keemink J; Mårtensson E; Bergström CAS
    Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
    Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
    J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations.
    Hedge OJ; Bergström CAS
    Pharm Res; 2020 May; 37(6):99. PubMed ID: 32435855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Cellular Monolayers and an Artificial Membrane as Absorptive Membranes in the in vitro Lipolysis-permeation Assay.
    Keemink J; Hedge OJ; Bianco V; Hubert M; Bergström CAS
    J Pharm Sci; 2022 Jan; 111(1):175-184. PubMed ID: 34516987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability.
    Tanaka Y; Nguyen TH; Suys EJA; Porter CJH
    Mol Pharm; 2021 Apr; 18(4):1768-1778. PubMed ID: 33729806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
    Dening TJ; Joyce P; Prestidge CA
    J Pharm Sci; 2019 Jan; 108(1):295-304. PubMed ID: 30257194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Int J Pharm; 2017 Jun; 526(1-2):95-105. PubMed ID: 28456653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
    Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
    AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability of two in vitro lipolysis models reflecting the human and rat gastro-intestinal conditions to predict the in vivo performance of SNEDDS dosing regimens.
    Siqueira Jørgensen SD; Al Sawaf M; Graeser K; Mu H; Müllertz A; Rades T
    Eur J Pharm Biopharm; 2018 Mar; 124():116-124. PubMed ID: 29288805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation.
    Larsen AT; Ohlsson AG; Polentarutti B; Barker RA; Phillips AR; Abu-Rmaileh R; Dickinson PA; Abrahamsson B; Ostergaard J; Müllertz A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):339-50. PubMed ID: 23178440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.